Patents Represented by Attorney Eliass J. Lambiris, Esq.

Find this attorney in the Justia Lawyer Directory

  • Method of reducing blood glucose
    Patent number: 5741791
    Abstract: The present invention relates to the use of compounds of the general formula ##STR1## for reducing blood glucose and/or inhibit the secretion, circulation or effect of insulin antagonizing peptides like CGRP or amylin. Hence the compound can be used in the treatment of insulin resistance related to NIDDM (non-insulin-dependent diabetes mellitus) or aging.
    Type: Grant
    Filed: December 13, 1996
    Date of Patent: April 21, 1998
    Assignee: Novo Nordisk A/S
    Inventor: Uffe Bang Olsen